Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07160777

Performance and Safety of Semical Dermal Fillers in Facial Rejuvenation

A Single Center Study Evaluating The Clinical Performance and Safety of Hyaluronic Acid-Based Implantable Dermal Fillers Applied to the Face

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Semikal Technology · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to verify safety and performance of Semical dermal fillers according to real-world data.

Detailed description

This study is a single-center, open label clinical follow-up study. The records of volunteers who were treated with Semical brand dermal fillers on the face at the research center and whose photographs are keps in the researcher's records will be evaluated retrospectively by the principle investigator and an independent evaluator. Volunteers who were used in accordance with the current intended use declared by the manufacturer of Semical Fine, Plus, Ultra Dermal Fillers and Mesolifter as applied in routine practice by the researcher may be included. The dermal filler application must have been applied to the necessary and determined facial areas, expectations, product safety requirements, and skin structure, with the technique deemed appropriate by the researcher. In order to obtain optimal aesthetic results, an optional touch-up application may have been made 4 weeks after the first application.

Conditions

Interventions

TypeNameDescription
DEVICEcross-linked hyaluronic acidSemical Dermal Filler Fine Semical Dermal Filler Plus Semical Dermal Filler Ultra
DEVICEMesolifterStabilized hyaluronic acid with NONASEM Technology. Application with Multi-Aesthetic Point Technique (MAPs)

Timeline

Start date
2024-11-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2025-09-08
Last updated
2025-09-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07160777. Inclusion in this directory is not an endorsement.